4//SEC Filing
Ballinger Kevin J. 4
Accession 0001140361-24-041421
CIK 0001397702other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 8:48 PM ET
Size
5.3 KB
Accession
0001140361-24-041421
Insider Transaction Report
Form 4
Ballinger Kevin J.
Director
Transactions
- Disposition to Issuer
Common Stock
2024-09-17−23,666→ 0 total
Footnotes (3)
- [F1]Of the reported shares, 5,859 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock.
- [F2]Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the "Merger Agreement"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding taxes.
- [F3]Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001566080
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 8:48 PM ET
- Size
- 5.3 KB